carboxyebselen has been researched along with cefaclor anhydrous in 1 studies
| Studies (carboxyebselen) | Trials (carboxyebselen) | Recent Studies (post-2010) (carboxyebselen) | Studies (cefaclor anhydrous) | Trials (cefaclor anhydrous) | Recent Studies (post-2010) (cefaclor anhydrous) |
|---|---|---|---|---|---|
| 6 | 0 | 5 | 919 | 260 | 92 |
| Protein | Taxonomy | carboxyebselen (IC50) | cefaclor anhydrous (IC50) |
|---|---|---|---|
| carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 isoform 1 | Homo sapiens (human) | 7.184 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, EWC; Chan, KF; Chan, TH; Chen, S; Cheng, Q; Gao, W; Jin, WB; Leung, YC; Qi, XL; Wong, KY; Xu, C; Zheng, Z | 1 |
1 other study(ies) available for carboxyebselen and cefaclor anhydrous
| Article | Year |
|---|---|
Investigation of synergistic antimicrobial effects of the drug combinations of meropenem and 1,2-benzisoselenazol-3(2H)-one derivatives on carbapenem-resistant Enterobacteriaceae producing NDM-1.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; HeLa Cells; Humans; Meropenem; Molecular Structure; Organoselenium Compounds; Structure-Activity Relationship; Thienamycins | 2018 |